March 25, 2014 - The Journal of Vascular and Interventional Radiology—the Society of Interventional Radiology’s peer-reviewed scientific journal—together with SIR Foundation, will present the 2013 JVIR Editor’s Award for Outstanding Clinical Research Paper and the Award for Outstanding Laboratory Investigation during the March 24 plenary session at SIR’s 39th Annual Scientific Meeting. SIR 2014 is being held March 22–27, 2014, in San Diego.
Eliseo Vano, PhD, an adviser to the Spanish Ministry of Health for radiation protection in medical exposures, received the 2013 JVIR Editor’s Award for Outstanding Clinical Research Paper for “Radiation-associated Lens Opacities in Catheterization Personnel: Results of a Survey and Direct Assessments.” Vano, who has for the last 20 years led a research team funded by Spanish organizations and the European Commission focused on radiation protection in medical imaging and interventional radiology, is professor of medical physics on the faculty of medicine of the Complutense University of Madrid and head of the medical physics service at Madrid’s San Carlos University Hospital. He is also a consultant to the International Atomic Energy Agency (IAEA) for topics concerning radiation safety in diagnostic and interventional radiology.
Marwan Moussa, MD, University of Arkansas Medical School’s department of radiology, received the 2013 JVIR Editor’s Award for Outstanding Laboratory Investigation for “Adjuvant Liposomal Doxorubicin Markedly Affects Radiofrequency Ablation-induced Effects on Periablational Microvasculature.” Before joining UAMS, Moussa spent three years working at the minimally invasive tumor therapy laboratory at Harvard’s Beth Israel Hospital in Boston, where he authored and co-authored several original articles and eight abstracts in the areas of combination radiofrequency ablation therapies and irreversible electroporation.
“The Journal of Vascular and Interventional Radiology prides itself on bringing high-level, evidence-based research to the fore,” said Ziv J Haskal, M.D., FSIR, editor-in-chief. “Dr. Vano’s article is an important one for radiology professionals; it is an in-depth demonstration of radiation eye injury risks to interventional personnel at occupational levels. Dr. Moussa’s paper examines chemotherapy delivery and its effects on surrounding tissue during radiofrequency ablation. Enhancing the effect of both of these potent image-guided therapies may allow us to more completely treat liver tumors,” said Haskal, a professor with the department of radiology and medical imaging at the University of Virginia Health System in Charlottesville. JVIR will continue to lead in publishing important studies that serve the global interventional and endovascular scientific community, said Haskal.
In addition, six additional Editor’s Award Honorees for Excellence in published clinical and laboratory investigations were named: Hideyuki Nishiofuku, M.D., Nara Medical University, Nara, Japan, “Transcatheter Arterial Chemoembolization Using Cisplatin Powder Mixed With Degradable Starch Microspheres for Colorectal Liver Metastases After FOLFOX Failure: Results of a Phase I/II Study”; Richard R. Saxon, M.D., FSIR, North County Radiology Medical Group, Oceanside, Calif., “Heparin-bonded, Expanded Polytetrafluoroethylene-lined Stent Graft in the Treatment of Femoropopliteal Artery Disease: One-year Results of the VIPER (Viabahn Endoprosthesis With Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) Trial”; Yan Yan, B.S., University of Pennsylvania Medical Center, Philadelphia, “Outcomes of Percutaneous Interventions in Transposed Hemodialysis Fistulas Compared With Nontransposed Fistulas and Grafts”; Rony Avritscher, M.D., the
University of Texas MD Anderson Cancer Center, Houston, “Percutaneous Intraportal Application of a Dipose Tissue-derived Mesenchymal Stem Cells Using a Balloon Occlusion Catheter in a Porcine Model of Liver Fibrosis”; Manon Buijs, M.D., Johns Hopkins Hospital, Baltimore, “Antiglycolytic Therapy Combined With an Image-guided Minimally Invasive Delivery Strategy for the Treatment of Breast Cancer”; and Ron C. Gaba, M.D., University of Illinois Medical Center at Chicago, “Transarterial Sorafenib Chemoembolization: Preliminary Study of Technical Feasibility in a Rabbit Model.”
Back To Top